Related Experiment Video
Updated: Jan 8, 2026

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
The Role of Donation After Circulatory Death in Heart Retransplantation: A United Organ Network for Organ Sharing
Kosuke Nakamae1, Sooyun Caroline Tavolacci2,3, Daisuke Onohara1,4
1From the Center for Regenerative Medicine, Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
Insights
Heart retransplantation (re-HT) using donors after circulatory death (DCD) is increasing. Early outcomes for re-HT with DCD donors are comparable to those using donors after brain death (DBD), supporting DCD utility.
Area of Science:
- Cardiology
- Transplantation Surgery
- Organ Donation
Background:
- Limited data exists on heart retransplantation (re-HT) utilizing donors after circulatory death (DCD).
- Understanding outcomes of re-HT with DCD donors is crucial for expanding the donor pool.
Purpose of the Study:
- To analyze and compare the outcomes of adult re-HT using donors after circulatory death (DCD) versus donors after brain death (DBD).
Main Methods:
- Analysis of the United Network for Organ Sharing (UNOS) registry data from 2018-2024.
- Inclusion of 630 adult recipients undergoing isolated re-HT or re-HT with simultaneous kidney transplantation.
- Comparison of recipient and donor characteristics, and clinical outcomes between DBD (n=578) and DCD (n=52) groups, including matched analysis.
Main Results:
- The proportion of re-HT using DCD donors significantly increased from 1.9% in 2020 to 24.1% in 2024.
- Post-matching, DCD donors had longer ischemic times and higher early graft dysfunction (24 hours).
- Comparable rates of acute rejection and 180-day survival were observed between DBD and DCD groups.
Conclusions:
- The utilization of DCD donors for re-HT has grown substantially.
- Early clinical outcomes for re-HT using DCD donors are similar to those using DBD donors.
- These findings support the clinical utility and safety of DCD donors for heart retransplantation.
Abstract:
There are limited data regarding heart retransplantation (re-HT) using donors after circulatory death (DCD). We analyzed outcomes of adult re-HT using the United Network for Organ Sharing (UNOS) registry. We identified 630 adult recipients who underwent isolated re-HT or re-HT with simultaneous kidney transplantation between 2018 and 2024. Recipient and donor characteristics, as well as clinical outcomes, were compared between brain death (DBD) (n = 578) and DCD (n = 52) groups. The proportion of re-HTs using DCD donors increased from 1.9% in 2020 to 24.1% in 2024 (95% confidence interval [CI], 48.2-110.9; p = 0.013). Before matching, the DBD group had a higher acuity of illness, with a significantly greater proportion listed as UNOS statuses 1-2 (57.0% vs. 15.0%; p < 0.001). After matching, the DCD group had significantly longer ischemic time (3.3 [2.6-3.9] vs. 4.0 [3.0-5.9] hours; p < 0.001), and a higher incidence of early post-transplant graft dysfunction at 24 hours (1.0% vs. 5.9%; p < 0.001). However, rates of acute rejection before discharge (19% vs. 14%, p = 0.63) and 180 day survival (95.0% [90.9-99.4] vs. 88.0% [79.4-97.5], p = 0.12) were comparable between groups. The use of DCD donors in re-HT has grown significantly and shows similar early outcomes to DBD donors. Our findings support the clinical utility of DCD for re-HT.
More Related Videos
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
07:49Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment
Published on: May 10, 2022
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...